Citius Oncology (CTOR) News Today $2.09 -0.73 (-25.85%) As of 01:59 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock CTOR Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Citius Oncology, Inc. Common Stock (CTOR) FinancialsJuly 11 at 5:22 AM | nasdaq.comCitius Oncology (NASDAQ:CTOR) Stock Price Up 1.9% - Here's WhyJuly 5, 2025 | americanbankingnews.comCitius Oncology (NASDAQ:CTOR) Stock Price Up 1.9% - Should You Buy?July 5, 2025 | marketbeat.comCitius Oncology Regains Nasdaq Compliance June 2025June 27, 2025 | tipranks.comCitius Oncology Anticipates Commercial Launch of LYMPHIR™ in 2025June 17, 2025 | prnewswire.comCitius Oncology stock soars on distribution dealJune 9, 2025 | in.investing.comCitius Oncology (NASDAQ:CTOR) Trading Up 3.4% - Here's WhyJune 6, 2025 | marketbeat.comMaxim Group Reiterates "Hold" Rating for Citius Oncology (NASDAQ:CTOR)May 25, 2025 | marketbeat.comMaxim Group Downgrades Citius Oncology (CTOR)May 24, 2025 | msn.comCitius Oncology (NASDAQ:CTOR) Trading Down 2.8% - Should You Sell?May 17, 2025 | marketbeat.comCitius Oncology, Inc. Reports Fiscal Second Quarter 2025 Financial Results and Provides Business UpdateMay 14, 2025 | prnewswire.comCitius Oncology, Inc. (NASDAQ:CTOR) Is Expected To Breakeven In The Near FutureMay 7, 2025 | finance.yahoo.comCitius Oncology, Inc. Common Stock (CTOR) Institutional HoldingsMay 5, 2025 | nasdaq.comCitius Pharmaceuticals to Present at the Jefferies Global Healthcare ConferenceMay 5, 2025 | prnewswire.comWall Street Set to Open Lower Monday as Investors Gird for More Tariffs, Await Key Manufacturing DataApril 1, 2025 | msn.comCitius Oncology (NASDAQ:CTOR) Shares Up 39.8% - Still a Buy?April 1, 2025 | marketbeat.comInvestors Brace for 'Liberation Day' as US Futures Trend Sharply Lower in Monday's PremarketMarch 31, 2025 | msn.comCitius Oncology (NASDAQ:CTOR) Stock Price Down 2.5% - What's Next?February 22, 2025 | marketbeat.comCTOR Citius Oncology, Inc.February 20, 2025 | seekingalpha.comCitius Oncology (NASDAQ:CTOR) Issues Earnings ResultsFebruary 15, 2025 | marketbeat.comCitius Oncology, Inc. Reports Fiscal First Quarter 2025 Financial Results and Provides Business UpdateFebruary 14, 2025 | prnewswire.comCitius Pharmaceuticals, Inc. Reports Fiscal First Quarter 2025 Financial Results and Provides Business UpdateFebruary 14, 2025 | prnewswire.comCitius Pharmaceuticals and Citius Oncology Announce Unique Permanent J-Code Issued for LYMPHIR by Centers for Medicare and Medicaid ServicesFebruary 6, 2025 | prnewswire.comCitius Oncology (NASDAQ:CTOR) Shares Down 2% - Should You Sell?January 30, 2025 | marketbeat.comCitius Oncology’s Strategic Positioning and Lymphir’s Market Launch Drive Buy RatingJanuary 10, 2025 | markets.businessinsider.comCitius Pharmaceuticals and Citius Oncology to launch Lymphir in 1H25January 8, 2025 | markets.businessinsider.comCitius Pharmaceuticals and Citius Oncology Highlight LYMPHIR Commercial Launch Planned for the First Half of 2025January 7, 2025 | prnewswire.comCitius Oncology Engages Jefferies as Exclusive Financial Advisor to Explore Strategic AlternativesJanuary 6, 2025 | prnewswire.comCitius Oncology, Inc. Reports Fiscal Full Year 2024 Financial Results and Provides Business UpdateDecember 28, 2024 | gurufocus.comCitius Oncology, Inc. Reports Fiscal Full Year 2024 Financial Results and Provides Business UpdateDecember 27, 2024 | prnewswire.comPromising Outlook for Citius Pharmaceuticals: Buy Rating Affirmed Amid Product Potential and Strategic DevelopmentsNovember 27, 2024 | markets.businessinsider.comCitius Pharmaceuticals, Citius Oncology report promising cancer trial resultsNovember 13, 2024 | markets.businessinsider.com Get Citius Oncology News Delivered to You Automatically Sign up to receive the latest news and ratings for CTOR and its competitors with MarketBeat's FREE daily newsletter. Email Address CTOR Media Mentions By Week CTOR Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CTOR News Sentiment▼0.941.01▲Average Medical News Sentiment CTOR News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CTOR Articles This Week▼20▲CTOR Articles Average Week Get Citius Oncology News Delivered to You Automatically Sign up to receive the latest news and ratings for CTOR and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Biohaven News Today Evotec News Today 89BIO News Today Janux Therapeutics News Today ANI Pharmaceuticals News Today Edgewise Therapeutics News Today Mesoblast News Today Travere Therapeutics News Today CureVac News Today Calliditas Therapeutics AB (publ) News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CTOR) was last updated on 7/14/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredCentral Banks Are Hoarding Gold – Should You?The AI boom isn’t just transforming technology—it’s redefining global power, increasing government debt, and u...Lear Capital | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Citius Oncology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Citius Oncology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CTOR Stock Alerts